1 Introduction to Research & Analysis Reports
1.1 Felodipine Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Felodipine Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Felodipine Tablets Overall Market Size
2.1 Global Felodipine Tablets Market Size: 2022 VS 2029
2.2 Global Felodipine Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Felodipine Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Felodipine Tablets Players in Global Market
3.2 Top Global Felodipine Tablets Companies Ranked by Revenue
3.3 Global Felodipine Tablets Revenue by Companies
3.4 Global Felodipine Tablets Sales by Companies
3.5 Global Felodipine Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Felodipine Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Felodipine Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Felodipine Tablets Players in Global Market
3.8.1 List of Global Tier 1 Felodipine Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Felodipine Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Felodipine Tablets Market Size Markets, 2022 & 2029
4.1.2 Ordinary Tablet
4.1.3 Sustained Release Tablet
4.2 By Type – Global Felodipine Tablets Revenue & Forecasts
4.2.1 By Type – Global Felodipine Tablets Revenue, 2018-2023
4.2.2 By Type – Global Felodipine Tablets Revenue, 2024-2029
4.2.3 By Type – Global Felodipine Tablets Revenue Market Share, 2018-2029
4.3 By Type – Global Felodipine Tablets Sales & Forecasts
4.3.1 By Type – Global Felodipine Tablets Sales, 2018-2023
4.3.2 By Type – Global Felodipine Tablets Sales, 2024-2029
4.3.3 By Type – Global Felodipine Tablets Sales Market Share, 2018-2029
4.4 By Type – Global Felodipine Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Felodipine Tablets Market Size, 2022 & 2029
5.1.2 Treat High Blood Pressure
5.1.3 Relieve Angina
5.1.4 Others
5.2 By Application – Global Felodipine Tablets Revenue & Forecasts
5.2.1 By Application – Global Felodipine Tablets Revenue, 2018-2023
5.2.2 By Application – Global Felodipine Tablets Revenue, 2024-2029
5.2.3 By Application – Global Felodipine Tablets Revenue Market Share, 2018-2029
5.3 By Application – Global Felodipine Tablets Sales & Forecasts
5.3.1 By Application – Global Felodipine Tablets Sales, 2018-2023
5.3.2 By Application – Global Felodipine Tablets Sales, 2024-2029
5.3.3 By Application – Global Felodipine Tablets Sales Market Share, 2018-2029
5.4 By Application – Global Felodipine Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Felodipine Tablets Market Size, 2022 & 2029
6.2 By Region – Global Felodipine Tablets Revenue & Forecasts
6.2.1 By Region – Global Felodipine Tablets Revenue, 2018-2023
6.2.2 By Region – Global Felodipine Tablets Revenue, 2024-2029
6.2.3 By Region – Global Felodipine Tablets Revenue Market Share, 2018-2029
6.3 By Region – Global Felodipine Tablets Sales & Forecasts
6.3.1 By Region – Global Felodipine Tablets Sales, 2018-2023
6.3.2 By Region – Global Felodipine Tablets Sales, 2024-2029
6.3.3 By Region – Global Felodipine Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Felodipine Tablets Revenue, 2018-2029
6.4.2 By Country – North America Felodipine Tablets Sales, 2018-2029
6.4.3 US Felodipine Tablets Market Size, 2018-2029
6.4.4 Canada Felodipine Tablets Market Size, 2018-2029
6.4.5 Mexico Felodipine Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Felodipine Tablets Revenue, 2018-2029
6.5.2 By Country – Europe Felodipine Tablets Sales, 2018-2029
6.5.3 Germany Felodipine Tablets Market Size, 2018-2029
6.5.4 France Felodipine Tablets Market Size, 2018-2029
6.5.5 U.K. Felodipine Tablets Market Size, 2018-2029
6.5.6 Italy Felodipine Tablets Market Size, 2018-2029
6.5.7 Russia Felodipine Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Felodipine Tablets Market Size, 2018-2029
6.5.9 Benelux Felodipine Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Felodipine Tablets Revenue, 2018-2029
6.6.2 By Region – Asia Felodipine Tablets Sales, 2018-2029
6.6.3 China Felodipine Tablets Market Size, 2018-2029
6.6.4 Japan Felodipine Tablets Market Size, 2018-2029
6.6.5 South Korea Felodipine Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Felodipine Tablets Market Size, 2018-2029
6.6.7 India Felodipine Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Felodipine Tablets Revenue, 2018-2029
6.7.2 By Country – South America Felodipine Tablets Sales, 2018-2029
6.7.3 Brazil Felodipine Tablets Market Size, 2018-2029
6.7.4 Argentina Felodipine Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Felodipine Tablets Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Felodipine Tablets Sales, 2018-2029
6.8.3 Turkey Felodipine Tablets Market Size, 2018-2029
6.8.4 Israel Felodipine Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Felodipine Tablets Market Size, 2018-2029
6.8.6 UAE Felodipine Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Company Summary
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca Felodipine Tablets Major Product Offerings
7.1.4 Astrazeneca Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.1.5 Astrazeneca Key News & Latest Developments
7.2 Sandoz
7.2.1 Sandoz Company Summary
7.2.2 Sandoz Business Overview
7.2.3 Sandoz Felodipine Tablets Major Product Offerings
7.2.4 Sandoz Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Sandoz Key News & Latest Developments
7.3 SHANXI KANGBO BIOLOGICAL PRODUCT
7.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Summary
7.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview
7.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Major Product Offerings
7.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Key News & Latest Developments
7.4 Changzhou Siyao Pharmaceutical
7.4.1 Changzhou Siyao Pharmaceutical Company Summary
7.4.2 Changzhou Siyao Pharmaceutical Business Overview
7.4.3 Changzhou Siyao Pharmaceutical Felodipine Tablets Major Product Offerings
7.4.4 Changzhou Siyao Pharmaceutical Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.4.5 Changzhou Siyao Pharmaceutical Key News & Latest Developments
7.5 Lianhuan Pharma
7.5.1 Lianhuan Pharma Company Summary
7.5.2 Lianhuan Pharma Business Overview
7.5.3 Lianhuan Pharma Felodipine Tablets Major Product Offerings
7.5.4 Lianhuan Pharma Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Lianhuan Pharma Key News & Latest Developments
7.6 Sihuan Pharma
7.6.1 Sihuan Pharma Company Summary
7.6.2 Sihuan Pharma Business Overview
7.6.3 Sihuan Pharma Felodipine Tablets Major Product Offerings
7.6.4 Sihuan Pharma Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.6.5 Sihuan Pharma Key News & Latest Developments
7.7 CR Double Crane
7.7.1 CR Double Crane Company Summary
7.7.2 CR Double Crane Business Overview
7.7.3 CR Double Crane Felodipine Tablets Major Product Offerings
7.7.4 CR Double Crane Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.7.5 CR Double Crane Key News & Latest Developments
7.8 Xiehe Pharma
7.8.1 Xiehe Pharma Company Summary
7.8.2 Xiehe Pharma Business Overview
7.8.3 Xiehe Pharma Felodipine Tablets Major Product Offerings
7.8.4 Xiehe Pharma Felodipine Tablets Sales and Revenue in Global (2018-2023)
7.8.5 Xiehe Pharma Key News & Latest Developments
8 Global Felodipine Tablets Production Capacity, Analysis
8.1 Global Felodipine Tablets Production Capacity, 2018-2029
8.2 Felodipine Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Felodipine Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Felodipine Tablets Supply Chain Analysis
10.1 Felodipine Tablets Industry Value Chain
10.2 Felodipine Tablets Upstream Market
10.3 Felodipine Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Felodipine Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のフェロジピン錠市場予測2023-2029：一般錠、徐放錠 |
| 【英語タイトル】Felodipine Tablets Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5560 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：77 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のフェロジピン錠市場規模と予測を収録しています。・世界のフェロジピン錠市場：売上、2018年-2023年、2024年-2029年 ・世界のフェロジピン錠市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のフェロジピン錠市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「一般錠」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 フェロジピン錠のグローバル主要企業は、Astrazeneca、 Sandoz、 SHANXI KANGBO BIOLOGICAL PRODUCT、 Changzhou Siyao Pharmaceutical、 Lianhuan Pharma、 Sihuan Pharma、 CR Double Crane、 Xiehe Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、フェロジピン錠のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のフェロジピン錠市場：タイプ別、2018年-2023年、2024年-2029年 世界のフェロジピン錠市場：タイプ別市場シェア、2022年 ・一般錠、徐放錠 世界のフェロジピン錠市場：用途別、2018年-2023年、2024年-2029年 世界のフェロジピン錠市場：用途別市場シェア、2022年 ・高血圧治療、狭心症緩和、その他 世界のフェロジピン錠市場：地域・国別、2018年-2023年、2024年-2029年 世界のフェロジピン錠市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるフェロジピン錠のグローバル売上、2018年-2023年 ・主要企業におけるフェロジピン錠のグローバル売上シェア、2022年 ・主要企業におけるフェロジピン錠のグローバル販売量、2018年-2023年 ・主要企業におけるフェロジピン錠のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Astrazeneca、 Sandoz、 SHANXI KANGBO BIOLOGICAL PRODUCT、 Changzhou Siyao Pharmaceutical、 Lianhuan Pharma、 Sihuan Pharma、 CR Double Crane、 Xiehe Pharma ************************************************************* ・調査・分析レポートの概要 フェロジピン錠市場の定義 市場セグメント 世界のフェロジピン錠市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のフェロジピン錠市場規模 世界のフェロジピン錠市場規模：2022年 VS 2029年 世界のフェロジピン錠市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのフェロジピン錠の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のフェロジピン錠製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：一般錠、徐放錠 フェロジピン錠のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：高血圧治療、狭心症緩和、その他 フェロジピン錠の用途別グローバル売上・予測 ・地域別市場分析 地域別フェロジピン錠市場規模 2022年と2029年 地域別フェロジピン錠売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Astrazeneca、 Sandoz、 SHANXI KANGBO BIOLOGICAL PRODUCT、 Changzhou Siyao Pharmaceutical、 Lianhuan Pharma、 Sihuan Pharma、 CR Double Crane、 Xiehe Pharma ... |
Felodipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. Felodipine relaxes blood vessels and increases the supply of blood and oxygen to the heart, which reduces the workload.
This report aims to provide a comprehensive presentation of the global market for Felodipine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Tablets. This report contains market size and forecasts of Felodipine Tablets in global, including the following market information:
Global Felodipine Tablets Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Felodipine Tablets Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Felodipine Tablets companies in 2022 (%)
The global Felodipine Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ordinary Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Felodipine Tablets include Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical, Lianhuan Pharma, Sihuan Pharma, CR Double Crane and Xiehe Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Felodipine Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Felodipine Tablets Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Felodipine Tablets Market Segment Percentages, by Type, 2022 (%)
Ordinary Tablet
Sustained Release Tablet
Global Felodipine Tablets Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Felodipine Tablets Market Segment Percentages, by Application, 2022 (%)
Treat High Blood Pressure
Relieve Angina
Others
Global Felodipine Tablets Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Felodipine Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Felodipine Tablets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Felodipine Tablets revenues share in global market, 2022 (%)
Key companies Felodipine Tablets sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Felodipine Tablets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
Sandoz
SHANXI KANGBO BIOLOGICAL PRODUCT
Changzhou Siyao Pharmaceutical
Lianhuan Pharma
Sihuan Pharma
CR Double Crane
Xiehe Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Felodipine Tablets, market overview.
Chapter 2: Global Felodipine Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Felodipine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Felodipine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Felodipine Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のフェロジピン錠市場予測2023-2029：一般錠、徐放錠] (コード：MMG23JU5560)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のフェロジピン錠市場予測2023-2029：一般錠、徐放錠]についてメールでお問い合わせ |
